These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23828321)

  • 21. Heterologous expression and characterization of a rare Gaucher disease mutation (c.481C > T) from a Canadian aboriginal population using archival tissue samples.
    Sinclair G; Choy FY; Ferreira P
    Mol Genet Metab; 2001 Nov; 74(3):345-52. PubMed ID: 11708865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gaucher disease in South Africa.
    Heitner R
    S Afr Med J; 2008 Jan; 98(1):11-2. PubMed ID: 18270627
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular analysis of Turkish Gaucher disease patients: identification of novel mutations in glucocerebrosidase (GBA) gene.
    Emre S; Gürakan F; Yüce A; Rolf A; Scott R; Ozen H
    Eur J Med Genet; 2008; 51(4):315-21. PubMed ID: 18586596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variant Gaucher disease characterized by dysmorphic features, absence of cardiovascular involvement, laryngospasm, and compound heterozygosity for a novel mutation (D409H/C16S).
    Bodamer OA; Church HJ; Cooper A; Wraith JE; Scott CR; Scaglia F
    Am J Med Genet; 2002 May; 109(4):328-31. PubMed ID: 11992489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocerebrosidase (Gaucher disease).
    Beutler E; Gelbart T
    Hum Mutat; 1996; 8(3):207-13. PubMed ID: 8889578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type 1 Gaucher disease: identification of N396T and prevalence of glucocerebrosidase mutations in the Portuguese.
    Amaral O; Pinto E; Fortuna M; Lacerda L; Sá Miranda MC
    Hum Mutat; 1996; 8(3):280-1. PubMed ID: 8889591
    [No Abstract]   [Full Text] [Related]  

  • 27. A mutation within the saposin D domain in a Gaucher disease patient with normal glucocerebrosidase activity.
    Diaz-Font A; Cormand B; Santamaria R; Vilageliu L; Grinberg D; Chabás A
    Hum Genet; 2005 Jul; 117(2-3):275-7. PubMed ID: 15856305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a novel recombinant allele in three unrelated Italian Gaucher patients: implications for prognosis and genetic counseling.
    Filocamo M; Bonuccelli G; Mazzotti R; Giona F; Gatti R
    Blood Cells Mol Dis; 2000 Aug; 26(4):307-11. PubMed ID: 11042032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gaucher mutation N188S is associated with myoclonic epilepsy.
    Kowarz L; Goker-Alpan O; Banerjee-Basu S; LaMarca ME; Kinlaw L; Schiffmann R; Baxevanis AD; Sidransky E
    Hum Mutat; 2005 Sep; 26(3):271-3; author reply 274-5. PubMed ID: 16086325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.
    Stone DL; Tayebi N; Orvisky E; Stubblefield B; Madike V; Sidransky E
    Hum Mutat; 2000; 15(2):181-8. PubMed ID: 10649495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gaucher disease.
    Butters TD
    Curr Opin Chem Biol; 2007 Aug; 11(4):412-8. PubMed ID: 17644022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles.
    Sawkar AR; Adamski-Werner SL; Cheng WC; Wong CH; Beutler E; Zimmer KP; Kelly JW
    Chem Biol; 2005 Nov; 12(11):1235-44. PubMed ID: 16298303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gaucher disease in Colombia: mutation identification and comparison to other Hispanic populations.
    Pomponio RJ; Cabrera-Salazar MA; Echeverri OY; Miller G; Barrera LA
    Mol Genet Metab; 2005 Dec; 86(4):466-72. PubMed ID: 16185907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myoclonic epilepsy in Gaucher disease: genotype-phenotype insights from a rare patient subgroup.
    Park JK; Orvisky E; Tayebi N; Kaneski C; Lamarca ME; Stubblefield BK; Martin BM; Schiffmann R; Sidransky E
    Pediatr Res; 2003 Mar; 53(3):387-95. PubMed ID: 12595585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gaucher disease: functional expression of the normal glucocerebrosidase and Gaucher T1366G and G1604A alleles in Baculovirus-transfected Spodoptera frugiperda cells.
    Choy FY; Wei C; Levin D
    Am J Med Genet; 1996 Oct; 65(3):184-9. PubMed ID: 9240741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease.
    McEachern KA; Nietupski JB; Chuang WL; Armentano D; Johnson J; Hutto E; Grabowski GA; Cheng SH; Marshall J
    J Gene Med; 2006 Jun; 8(6):719-29. PubMed ID: 16528760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aminocyclitols as pharmacological chaperones for glucocerebrosidase, a defective enzyme in Gaucher disease.
    Egido-Gabás M; Canals D; Casas J; Llebaria A; Delgado A
    ChemMedChem; 2007 Jul; 2(7):992-4. PubMed ID: 17479993
    [No Abstract]   [Full Text] [Related]  

  • 38. Gaucher disease in a Turkish family.
    Turfaner Ertürk N; Karter Y; Tunçkale A; Emre S; Erdoğan C; Taşan E; Oztürk E
    Genet Couns; 2002; 13(3):357-8. PubMed ID: 12416646
    [No Abstract]   [Full Text] [Related]  

  • 39. A novel complex allele and two new point mutations in type 2 (acute neuronopathic) Gaucher disease.
    Sinclair G; Choy FY; Humphries L
    Blood Cells Mol Dis; 1998 Dec; 24(4):420-7. PubMed ID: 9851895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
    Tóth J; Szücs FZ; Benkö K; Maródi L
    Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.